Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

CymaBay Therapeutics, Inc. (CBAY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.9900+0.1000 (+3.46%)
At close: 04:00PM EST
2.9800 -0.01 (-0.33%)
After hours: 05:52PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close2.8900
Open2.9100
Bid2.7400 x 1800
Ask2.9900 x 800
Day's Range2.7800 - 3.0000
52 Week Range2.7600 - 6.5600
Volume641,344
Avg. Volume543,067
Market Cap253.16M
Beta (5Y Monthly)1.08
PE Ratio (TTM)N/A
EPS (TTM)-1.1480
Earnings DateMar 23, 2022 - Mar 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.10
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CBAY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CymaBay Therapeutics Inc.
    Daily – Vickers Top Buyers & Sellers for 01/21/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
Advertisement
Advertisement